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Abstract
Background
The growth potential of the tumor-like Echinococcus multilocularismetacestode (causing
alveolar echinococcosis, AE) is directly linked to the nature/function of the periparasitic host
immune-mediated processes. We previously showed that Fibrinogen-like-protein 2 (FGL2),
a novel CD4+CD25+ Treg effector molecule, was over-expressed in the liver of mice experi-
mentally infected with E.multilocularis. However, little is known about its contribution to the
control of this chronic helminth infection.
Methods/Findings
Key parameters for infection outcome in E.multilocularis-infected fgl2-/- (AE-fgl2-/-) and wild
type (AE-WT) mice at 1 and 4 month(s) post-infection were (i) parasite load (i. e. wet weight of
parasitic metacestode tissue), and (ii) parasite cell proliferation as assessed by determining
E.multilocularis 14-3-3 gene expression levels. Serum FGL2 levels were measured by
ELISA. Spleen cells cultured with ConA for 48h or with E.multilocularisVesicle Fluid (VF) for
96h were analyzed ex-vivo and in-vitro. In addition, spleen cells from non-infectedWTmice
were cultured with rFGL2/anti-FGL2 or rIL-17A/anti-IL-17A for further functional studies. For
Treg-immune-suppression-assays, purified CD4+CD25+ Treg suspensions were incubated
with CD4+ effector T cells in the presence of ConA and irradiated spleen cells as APCs. Flow
cytometry and qRT-PCRwere used to assess Treg, Th17-, Th1-, Th2-type immune
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responses and maturation of dendritic cells. We showed that AE-fgl2-/-mice exhibited (as
compared to AE-WT-animals) (a) a significantly lower parasite load with reduced proliferation
activity, (b) an increased T cell proliferative response to ConA, (c) reduced Treg numbers and
function, and (d) a persistent capacity of Th1 polarization and DCmaturation.
Conclusions
FGL2 appears as one of the key players in immune regulatory processes favoring metaces-
tode survival by promoting Treg cell activity and IL-17A production that contributes to FGL2-
regulation. Prospectively, targeting FGL2 could be an option to develop an immunotherapy
against AE and other chronic parasitic diseases.
Author Summary
In larval E.multilocularis infection causing alveolar echinococcosis (AE) in humans as
well as mice, immune tolerance and/or down-regulation of protective immunity is a
marked characteristic of this chronic disease. Our study provides a comprehensive evi-
dence for a major involvement of the recently identified CD4+ CD25+ Regulatory T Cell
Effector Molecule FGL2 to the outcome of AE. Our major findings are as follows: 1) FGL2
is mostly secreted by Tregs and partly contributes to their functions; 2) FGL2 can down-
regulate the maturation of DCs, suppress Th1 and Th17 immune responses, and support
Th2 and Treg immune responses, and finally 3) IL-17A contributes to FGL2 secretion.
Based on the present findings in mice, we will investigate FGL2 as a potential marker of
progression of AE in human patients, or as a potential immunotherapeutical target. Early
prediction of parasite regression (currently not yet possible) would allow clinicians to plan
for withdrawing benzimidazole treatment, which is currently administered for life. Then,
FGL2 should be investigated as a target for an anticipated immunomodulatory treatment
of patients with progressive AE, especially of those who are non- or low-responders to
benzimidazole treatment, or who suffer from side-effects due to chemotherapy.
Introduction
Alveolar echinococcosis (AE) is a very severe zoonotic helminthic disease in humans, exhibit-
ing a fatal outcome if remaining untreated [1]. AE is characterized by chronic and progressive
hepatic damage caused by the continuous proliferation of the larval stage (metacestode) of
Echinococcus multilocularis [2], that behaves like a slowly growing liver cancer, progressively
invading host tissues and organs [3].
During E.multilocularis infections in humans, a Th2-oriented immunity is basically associ-
ated with increased susceptibility to disease leading to chronic AE, while Th1 cell activation
has been linked to protectivity, which may even yield aborted ("died-out") forms of infection
[2,3]. Experimental murine AE is characterized, as studied in spleen or lymph node cells, by an
initial Th1 response during the early stage of infection (till 1 month p.i.) that gradually switches
to a more dominant Th2-biased response during the chronic phase of AE (2–4 months p.i.).
Nevertheless, this mostly mixed Th1/Th2 profile, characterized by the concomitant presence of
IL-12α, IFN-γ and IL-4 at the very early stage of E.multilocularis infection [4], is associated
FGL2 in Murine Alveolar Echinococcosis
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with the expression of pro-inflammatory cytokines in the periparasitic granuloma and partial/
relative protective immunity (restriction of parasite growth) through fibrosis and necrosis [5].
It has been previously reported that CD4+CD25+ T regulatory cells (Tregs) play a critical role
in human AE by blunting immune responses to specific antigens, or by suppressing the secre-
tion of proinflammatory cytokines, especially through interleukin (IL)-10 and transforming
growth factor beta1 (TGF-β1) [6]. Moreover, increased CD4+CD25+ Tregs were also observed
in peritoneal cells of mice intraperitoneally (i.p.) infected with E.multilocularis, a finding that
concurred with other findings demonstrating that E.multilocularis antigens promote T cell dif-
ferentiation into Treg cells [7].
Previous microarray analyses showed that expression of mRNA coding for the fibrinogen-
like protein 2 (FGL2) were significantly up-regulated in the liver of mice perorally infected
with E.multilocularis eggs [8]. FGL2, a member of the fibrinogen-related superfamily of pro-
teins secreted by T cells, has recently been reported by a number of groups to be highly express-
ed in Tregs. Its role was associated to Treg effector functions [9,10]. It was shown that FGL2
could inhibit dendritic cell (DC) maturation through binding to the low-affinity FcgammaRIIB
receptor, and thus contribute to Treg activity [11]. There is evidence that FGL2 exerts an im-
munosuppressive effect on T cell proliferation. Thus, FGL2 seems to play an important role
both in innate and adaptive immunity, by the fact to be expressed by activated CD4+ and CD8+
T cells, and reticulo-endothelial cells as well [12–17]. FGL2 has been propagated as a novel can-
cer biomarker, and was shown to be involved in the pathogenesis of inflammatory disorders
such as allo- and xenograft rejection [12,18–22] and cytokine-induced fetal loss [23], as well as
in the pathogenesis of infectious diseases, such as viral hepatitis [14,17]. However, nothing is
known about FGL2 and its potential role in parasite-induced immunotolerance.
The major aims of this work were thus: 1) to study the role of FGL2 in T cell reactivity as
well as its effect on the maturation of DCs in an early time-point and a late stage of E.multilo-
cularis infection in fgl2 knock-out (fgl2-/-) mice; 2) to elucidate how parasite components, i.e.
metabolites represented by those expressed in the VF of the E.multilocularismetacestode, af-
fect the immune response in fgl2-/- mice; 3) to explore how FGL2 is secreted during the course
of E.multilocularis infection; and 4) to provide a comprehensive picture of the various cell and
molecular components involved in the regulation of the peritoneal periparasitic immune cell
infiltrate, and likewise in the spleen as a key immune organ. To achieve these goals, Th1/
Th2-related and Treg/Th17 related cytokines, the maturation of DCs, and the generation of
Tregs and their functions were studied at the different disease stages in an experimental model
with active or knocked-out FGL2-expression.
Materials and Methods
Ethics statement
The animal study was performed in strict accordance with the recommendations of the Swiss
Guidelines for the Care and Use of Laboratory Animals. The protocol was approved by the
Commission for Animal Experimentation of the Canton of Bern (approval no. BE_103/11).
Mice, parasites and infection
8-week-old female C57/BL6 (wild type [WT]) and C57/BL6 fgl2-/- mice [24] were bred and
housed in specific-pathogen-free (SPF) facilities according to recommendations of FELASA,
and monitored by daily assessment of health status, putative weight loss or gain during the ex-
periments. E.multilocularismetacestodes (clone KF5) were maintained by serial passages (veg-
etative transfer) in C57BL/6 mice [25] and injected intraperitoneally as previously described
[26,27]. Each experimental group included 6 animals unless otherwise stated. Control mice
FGL2 in Murine Alveolar Echinococcosis
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(mock-infection) received 100 μL of RPMI-1640 only. Mice were sacrificed at 1 or 4 month(s)
post-infection, corresponding to early and late stage of disease, respectively. Parasite tissues
were surgically recovered and, if present, fat and connective tissues were carefully removed for
subsequent wet-weight determination of the parasite mass.
E.multilocularis 14-3-3 gene-expression analyses by quantitative
reverse transcriptase real time PCR (qRT-PCR)
Total RNA was extracted from parasite tissue previously put into TRIzol (Invitrogen) according
to the manufacturer’s instructions. cDNA was synthesized using the Omniscript Reverse Tran-
scription kit (Qiagen, Hilden, Germany). SYBR-Green Mix-based qRT-PCR was carried out on a
Rotor-Gene 6000 qPCR detection system (Corbett) with the FastStart Essential DNA GreenMas-
ter (Roche, Basel, Switzerland) following the manufacturer’s instructions. PCR cycling was per-
formed in triplicates in final volumes of 20 μL containing 2 μL cDNA and 10 pM of each primer
(Cycle scheme: initial denaturation at 95°C—15 min, 45 cycles of 95°C—15 s, 55°C—30 s and
72°C—30 s). Fluorescence was measured in every cycle, and a melting curve was analyzed after
the PCR by increasing the temperature from 55 to 95°C in 0.5°C increments. The primers used
were described earlier [28], and em14-3-3mRNA levels were quantified relative to the mRNA
level of a parasite housekeeping gene, the β-actin homologue E.multilocularis. Respective mean
values from triplicate determinations from 6 individual mice in each group were taken for the
calculation of relative emII/3 and em14-3-3mRNA levels in relation to em-β-actinmRNA levels).
Cell preparations and Treg suppression assay
Peritoneal exudate cells (PEC) and spleen cells were collected by peritoneal rinsing or grinding in
5 mL RPMI-1640 (Gibco, Basel, Switzerland) and incubation of PEC or spleen cell suspensions
in 15 mL RPMI-1640 +20%FCS in a petridish for 2 h at 37°C 5%CO2, as described earlier [25].
The non-adherent cells were collected, and highly (N99%) enriched iTreg cells were obtained by
MACS (magnetic cell-separation) using the mouse CD4+CD25+ T cell Isolation-Kit (Miltenyi
Biotec, Germany) followed by FACS.
In vitro suppression assays were carried out with cultures of 2×104 CD4+CD25- T effector
(Teff) cells fromWT-mice as responder cells, together with 8×104 irradiated spleen cells as APCs
and titrated numbers of CD4+CD25+ Treg cells from either E.multilocularis-infected AE-fgl2-/-
or AE-WTmice as suppressor-cells, compared with non-infected controls. For rFGL2/antibody
blockade studies, 1 μg/mLmouse rFGL2 or anti-FGL2- (monoclonal IgG2a; Abnova, Luzern,
Switzerland) were added to the cell cultures at a 1:1 Treg:Teff ratio in the presence of APCs and
ConA (2μg/mL). Cell proliferation was assayed using the colorimetric BrdU cell proliferation
ELISA kit (Calbiochem, Merck, Switzerland) according to manufacturer’s instructions.
Spleen cell stimulation assays and FGL2 measurement
Spleen cells were cultured at a density of 2×106 cells/mL in RPMI-1640 +10%FCS. For assess-
ment of the effects of stimulation by recombinant FGL2 (rFGL2) or anti-FGL2 monoclonal an-
tibodies (anti-FGL2-MAb), (both from Sigma-Aldrich, Basel, Switzerland) they were incubated
with 1 and 5 μg/mL rFGL2 or 1 μg/mL anti-FGL2-MAb for 48h in the presence of a protein
transport inhibitor cocktail (Ebioscience, San Diego, CA, USA) for cytokine staining. Negative
control reactions were performed without rFGL2 or without anti-FGL2-MAb. The effects of re-
combinant IL-17A (rIL-17A) anti-IL-17A antibodies (both from Sigma), were assessed by
stimulation of cells with 0.5, 1, 2 and 4 μg/mL rIL-17A or 1 μg/mL anti-IL-17A for 48h, while
negative control reactions were performed without rIL-17A or anti-IL-17A antibodies.
FGL2-levels in the serum and supernatant from cell cultures were measured by sandwich
FGL2 in Murine Alveolar Echinococcosis
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ELISA (Biolegend, San Diego, CA) according to manufacturer’s instructions. Spleen cell cul-
tures were also stimulated with 2 μg/mL ConA for 48h, or with 10μg/mL of VF for 96 h, in the
presence of protein transport inhibitor cocktail for cytokine staining. The same cell reactions
performed without VF were used as negative controls.
Flow cytometry
PEC or spleen cells were incubated with 1 μg of purified anti-CD16/CD32 for 20 min in the
dark to block non-specific binding of antibodies to the FcγIII/II receptors, cells were then
stained with surface markers separately for 15 min with 1 μg of primary antibodies: FITC-la-
beled anti-CD80, anti-CD86, anti-CD25; PE-labeled anti-CD11b, anti-CD11c, PECy 5.5-la-
beled anti-CD4. For intracellular staining, the cells were first incubated with Inside-Fix
(Miltenyi, Bergisch Gladbach, Germany) for 20 min at room temperature then stained with
PE-labeled anti-IFN-r, anti-IL-4, anti-IL-17A, anti-IL-2, anti-IL-10 and anti-Foxp3 in Inside-
Perm (Miltenyi, Bergisch Gladbach, Germany) for 15 min in the dark. Corresponding fluoro-
chrome-labeled isotype control antibodies were used for staining controls. For each sample, a
minimum of 500,000 cells were acquired using a FACS LSRII flow cytometer and analyzed
using FlowJo software (Tree Star, OR, USA), employing the gating strategy shown in S1 Fig.
All antibodies were purchased from BD Pharmingen (Palo Alto, USA).
Statistical analyses
All data were analyzed by SPSS 17.0. The results are presented as means ± SD. Normality of
data was assessed by D’Agostino & Pesrson and Shapiro-Willk test. For normally distributed
groups of data, One-way-ANOVA followed by Bonferroni’s post-test or unpaired two-tail Stu-
dent’s t-test were used to compare the differences between groups, and two-tail Spearman’s
rho was used to analyze the correlation coefficient. Significance was defined as P<0.05 for all
tests, except those subsequently corrected by Bonferroni.
Results
E.multilocularis infection induces FGL2 production through IL-17A
The levels of FGL2 expression in sera of E.multilocularis infected (AE-WT) mice were signifi-
cantly higher, both at 1 and at 4 month(s) post-infection, when compared to non-infected
WT-controls (Fig 1A). Spearman correlation coefficients indicated a positive correlation be-
tween serum IL-17A level and FGL2 (r = 0.435, P = 0.045) in AE-WT-mice. To examine
whether IL-17A contributes to FGL2-secretion, spleen cells from non-infected WT-mice were
co-cultured either with recombinant IL-17A (rIL-17A) as an external stimulus, or with anti-IL-
17A antibodies, and FGL2 levels were quantitatively analyzed in respective culture superna-
tants by ELISA. As shown in Fig 1B, addition of rIL-17A lead to increased FGL2-secretion in a
dose-dependent manner, while the addition of anti-IL-17A had no effect (Fig 1B).
FGL2 plays a critical role in the overall infection control
To characterize the role of FGL2 in the control of parasite growth, E.multilocularis-infected
fgl2-/- mice and control WT littermates were analyzed after 1 and 4 months p.i. with respect to
parasite weight and the expression of em14-3-3 as a marker for cellular proliferation activity
[24]. At the late stage of infection (4 months- p.i.), fgl2-/- mice exhibited a significantly lower
parasite load compared to WT mice (Fig 1C and 1D), and 14-3-3 expression levels in AE-fgl2-/-
mice were significantly lower those in AE-WTmice (Fig 1E). Moreover, the parasite invaded
FGL2 in Murine Alveolar Echinococcosis
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Fig 1. Serum FGL2 levels in E.multilocularis infectedmice, effect of IL-17A on FGL2 secretion in spleen cells, and effects of FGL2 on parasite load
and proliferation in E.multilocularis infectedmice. (A) Serum levels of FGL2 in infected AE-WTmice at differentstages of infection, as compared to non-
infected control mice (Control). (B) Different concentrations of recombinant IL-17A (0, 0.5, 1, 2 μg/mL) or anti-IL-17A MAbs (1 μg/ml) were added to primary
spleen cells isolated from non-infectedWTmice (4 months p.i.). FGL2-levels in culture supernatants were determined by ELISA. (C) Parasite load in AE-WT
and AE- fgl2-/-mice assessed by wet weight measurement at 1 month and 4 months post- infection. (D) Representative images of E.multilocularis infection
in AE-WT and AE-fgl2-/-mice at 4 months p.i.; arrows point at intraperitoneal metacestode tissue/lesions. (E) Parasite cell proliferation in AE-WT versus AE-
fgl2-/- assessed by em14-3-3 qRT-PCR at 4 months p.i, upon comparison to the constitutively expressed house-keeping Em II/3-10 gene. Data represent
mean ± SD of three independent experiments of a total of 15–18 mice in each group (5–6 mice per group in each independent experiment). Comparison
between groups was performed using a one-way ANOVA for statistical analysis. *P<0.05, ** P<0.01. ‘WT’, wild type mice; ‘fgl2-/-’, fgl2 knock-out mice;
‘AE-WT’, E.multilocularis-infected wild type mice; ‘AE-fgl2-/-’, E.multilocularis-infected fgl2 knock-out mice. ‘Control’, non-infected mice; ‘1m’, 1 month p.i.;
‘4m’, 4 months p.i. AU: arbitrary units. Note: Em 14-3-3 is used as a molecular marker to assess viability and growth activity of the E.multilocularis
metacestode tissue, whereas Em II/3-10, so as actin, serve as constitutionally expressed house-keeping gene.
doi:10.1371/journal.pntd.0003755.g001
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the liver (a marker of pathogenicity) in only 33.3% of the AE-fgl2-/- mice compared to 94.4% of
AE-WT mice.
FGL2 is mostly secreted by Tregs and affects Treg function at late stage
of infection
To explore the cellular source of secreted FGL2, CD4+ effector T cells (Teffs), CD8+ T cells,
CD4+CD25+ Tregs, antigen presenting cells (APCs) were FACS sorted from spleen cell suspen-
sions of AE-WT mice, and non-infected control mice. Quantitative RT-PCR showed that fgl2
mRNA-levels were significantly increased in CD4+CD25+ Tregs derived from AE-WT mice,
when compared to non-infected controls, while no significant changes were evident with re-
spect to CD4+ Teffs, CD8+ T cells. A slight decrease in FGL2 mRNA-levels were noted in APCs
from AE-WT mice compared to those in non-infected mice (Fig 2A).
The contribution of FGL2 in the generation and maintenance of Tregs in AE-WT and AE-
fgl2-/-mice was analyzed ex vivo, and in vitro by either addition of rFGL2 to spleen cells or treating
cultures with anti-FGL2 antibodies. At 4 months p.i., an increased frequency of Foxp3+/CD4+
CD25+ cells could be observed in PECs as well as spleen cells from AE-WTmice, compared to re-
spective preparations in AE-fgl2-/-mice (P<0.05) (Fig 2B and 2C). In addition, expression levels
of Foxp3 and IL-10-transcripts were significantly increased in PECs from AE-WTmice (Fig 2D).
Moreover, when in vitro cultured PECs from AE-WTmice were exposed to anti-FGL2-MAbs
and stimulated with VF, the frequency of CD4+CD25+Foxp3+ cells was decreased compared to
PECs cultured in the absence of anti-FGL2-MAbs (Fig 2E). This indicated that in the absence of
FGL2 E.multilocularismetabolic components might exert immune-modulatory activities.
We then assessed the effect of the targeted deletion of fgl2 on the ability of Treg cells to sup-
press the proliferation of Teffs. Treg cells from either non-infected or AE-fgl2-/-mice, were less ef-
ficient in suppressing normal CD4+ Teff cell proliferation when compared to Treg cells from
WT-mice (S2 Fig). To further study the role of FGL2 regarding Treg functions, spleen cells from
AE-WTmice were exposed to either anti-FGL2-MAb or rFGL2. In response to rFGL2, Tregs
from AE-WTmice inhibited ConA-induced CD4+ Teff proliferation; conversely, the same Tregs
were not able to inhibit CD4+ Teff proliferation in the presence of anti-FGL2-MAbs (Fig 2F).
T cell functions are less affected in fgl2-/-mice at the late stage of
infection
To further explore the effects of FGL2 on the immune response during E.multilocularis infection,
T cell functions, in AE-WT and AE-fgl2-/-mice were comparatively assessed. Purified splenic
CD4+ T cells from AE-fgl2-/-mice exhibited an increased proliferation in response to ConA, as
compared to splenic CD4+ T cells from AE-WTmice (P<0.01) (S3A and S3B Fig). To further
study the role of FGL2 in Tcell proliferation, splenic CD4+ T cells fromWTmice were cultured in
the presence and absence of rFGL2. CD4+ Teffs showed a pronounced proliferation in response to
ConA stimulation, which was inhibited by the addition of rFGL2 (S3C Fig). Furthermore, T help-
er (Th) cells from AE-fgl2-/-mice appeared oriented towards a lower Th2 response at early stage
of infection (1 months p.i.), and a stronger Th1-response at late stage of infection (4 months p.i.)
(Fig 3A–3C and 3E). This dichotomic polarization was, however, not confirmed by in vitro culti-
vation of the cells in the presence of ConA stimulation (Fig 3D). Respective flow cytometric analy-
ses of CD4+ T cells in spleen from AE-fgl2-/-mice and AE-WTmice showed that there was no
difference in expression of IFN-γ and IL-4 at 48 h after of exposure to ConA (Fig 3D). However,
expression levels of IL-17A and IL-2 were significantly higher in CD4+ T cells in spleen cell cul-
tures obtained from AE-fgl2-/-mice at 4 months p.i. when compared to AE-WTmice.
FGL2 in Murine Alveolar Echinococcosis
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Fig 2. Treg secretion and function in both AE-WT and AE-fgl2-/-mice after E.multilocularis infection, and inWTmice in response to recombinant
FGL2/anti-FGL2-MAb blockade. (A) Spleen was taken from non-infectedWT and AE-WTmice, CD4+ Teffs, CD8+ T cells, CD4+CD25+ Tregs and APCs
were isolated by FACS cell sorting, fgl2mRNA levels were determined by qRT-PCR. (B) Representative images of Foxp3 mean fluorescence intensity (MFI)
from AE-WT and AE-fgl2-/-mice, and non-infected mice as controls. (C) Frequency of Foxp3+ T cells within CD4+CD25+T cells in PECs and spleen cells from
AE-WT and AE-fgl2-/-mice at 1 month and 4 months post-infection. (D) Foxp3 and IL-10 gene expression in PECs during E.multilocularis infection
(measured by qRT-PCR). AU: arbitrary units. Graphs show the mean±SD. Data represent mean±SD of three independent experiments of a total 15–18 mice
in each group (5–6 mice per group in each independent experiment). Comparison between groups was performed using a one-way ANOVA for statistical
analysis. (E) 0, 1, and 5 μg/mL of recombinant FGL2 and 1μg/mL of anti-FGL2-MAb were added to primary spleen cells from non-infectedWTmice, or spleen
cells stimulated with ConA or vesicle fluid (VF). Relative expression levels of Foxp3+/CD4+CD25+ were determined by flow cytometry. (F) CD4+CD25+ Tregs
(suppressor cells) and CD4+CD25- Teff cells (responder cells) were isolated from spleen cells of both non-infected and infected AE-WTmice by FACS. The
two cell populations were co-cultured at a ratio of 1:1 (suppressor: responder) in the presence of APCs and ConA (2 μg/mL), rFGL2 (1 μg/mL), ConA
(2 μg/mL) + rFGL2 (1 μg/mL), or anti-FGL2-MAb (1 μg/mL); cell proliferation was measured using BrdU ELISA. Data represent mean±SD of three
independent experiments of a total of 15–18 mice in each group (5–6 mice per group in each independent experiment). Expression of Foxp3+/CD4+CD25+
was normalized with negative control (cells without rFGL2 and anti-FGL2-MAb (negative control) were considered as base line, e.g. as 1.0). Comparison
between groups was performed using a one-way ANOVAwith Bonferroni’s multiple comparison post-test for statistical analysis. *P<0.025 for ex vivo assay,
and *P<0.006 for in vitro assay. ‘WT’, wild type mice; ‘fgl2-/-’, fgl2 knock-out mice; ‘AE-WT’, E.multilocularis-infected wild type mice; ‘AE-fgl2-/-’, E.
multilocularis-infected fgl2 knock-out mice. ‘PEC’, peritoneal exudate cells; ‘Spleen’, spleen cells; VF, vesicle fluid.
doi:10.1371/journal.pntd.0003755.g002
FGL2 in Murine Alveolar Echinococcosis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003755 May 8, 2015 8 / 20
DCmaturation is less affected in absence of FGL2 at the late stage of
infection
The role of FGL2 in the maturation of different subsets of DCs, i.e. CD11b+ and CD11c+ DCs,
was investigated. First, the maturation levels in both PECs and spleen cells from infected AE-
fgl2-/-mice, AE-WT mice, and non-infected controls were studied. Among CD11b+ DCs, the
frequency of the maturation marker CD80 in PECs and spleen cells was higher at 4 months p.i.
Fig 3. T cell function in both AE-WT and AE-fgl2-/-mice at 1 months and 4months post-infection. (A) Frequency of IFN-γ+ T cells within CD4+ T cells in
peritoneal and spleen cells from AE-WT and AE-fgl2-/-mice. (B) Representative images of IFN-γ+ T cells within CD4+ T cells in PECs and spleen cells from
both AE-WT and AE-fgl2-/-mice at 4 months post-infection. (C) Frequency of IL-4+ T cells within CD4+ T cells in PECs and spleen cells from AE-WT and AE-
fgl2-/-mice. (D) Relative level of T cell reactivity markers in spleen cells from AE-WT and AE-fgl2-/-mice, co-cultured with ConA (2 μg/mL), normalized with
their corresponding non-infected controls (non-infected control was considered as baseline, e.g. 1.0). (E) Representative images of IL-4+ T cells within CD4+
T cells in PECs and spleen cells from both AE-WT and AE-fgl2-/-mice at 1 month post E.multilocularis infection. The corresponding isotype control
antibodies were identically labeled as staining controls. Data represent mean±SD of three independent experiments of a total of 15–18 mice in each group
(5–6 mice per group in each independent experiment). Comparison between groups was performed using a one-way ANOVA with Bonferroni’s multiple
comparison post-test for statistical analysis. *P<0.025 for ex vivo assay, and *P<0.006 for in vitro assay. ‘WT’, wild type mice; ‘fgl2-/-’, fgl2 knock-out mice;
‘AE-WT’, E.multilocularis-infected wild type mice; ‘AE-fgl2-/-’, E.multilocularis-infected fgl2 knock-out mice. ‘PEC’, peritoneal exudate cells; ‘Spleen’,
spleen cells.
doi:10.1371/journal.pntd.0003755.g003
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in AE-fgl2-/- mice than in AE-WT mice (Fig 4A and 4B). The same was found for CD11c+ DCs
(Fig 4G and 4H). However, there was no difference in CD86 frequency in both subpopulations
of DCs (Fig 4D and 4E). Subsequently, we assessed the same parameters, but upon in vitro cul-
tivation and stimulation with ConA for 48 h. Findings revealed that CD80 frequency, not
CD86, in both DC subpopulations from AE-fgl2-/- mice at 4 months p.i. was significantly
higher than in those from AE-WT mice (Fig 4C,4F and 4I).
E.multilocularis vesicle VF modulates T cell functions and DC
maturation
Flow cytometry of spleen cells exposed to VF for 96 h showed that the expression of IL-2 was
significantly higher in CD4+ cells from AE-fgl2-/- mice obtained after 4 months p.i. than in the
corresponding cell population isolated from AE-WTmice. However, there was no difference in
expression of IFN-γ, IL-4 or IL-17A between CD4+ cells from AE-fgl2-/- mice and AE-WT
mice (Fig 5A). To further explore the role of VF on Tregs and FGL2 secretion, respectively,
spleen cells from AE-WT mice and non-infected WT controls were each cultured in the pres-
ence of VF (10 μg/mL). FGL2 levels in the supernatants were determined by ELISA. An identi-
cal experiment was performed with CD4+CD25+ Tregs and CD4+ Teffs instead of spleen cells,
in the presence of APCs. No differences in FGL2 levels in supernatants of sorted AE-WT
Tregs, nor in CD4+ Teffs, could be detected in response to VF, when compared to cultures
from non-infected animals (S4 Fig).
For DCs at 96 h after exposure to VF, the CD80 frequency, both in CD11b+ and CD11c+
DCs from AE-fgl2-/- mice at 4 months p.i., was significantly higher than in DCs from AE-WT
mice. However, there was no difference in CD86 frequency in both subpopulations of DCs
from AE-fgl2-/- mice after exposure to VF, compared to DCs from AE-WT mice (Fig 5B).
Recombinant FGL2 and anti-FGL2–MAbs affect T cell functions, co-
stimulation and DCmaturation in spleen cells from non-infectedWT
mice
To further confirm the role of FGL2 on T cell functions and DC maturation, spleen cells from
non-infected WTmice were cultured in the presence or absence of rFGL2 or anti-FGL2-MAbs.
Flow cytometry showed that IFN-γ expression was specifically increased in response to VF in
the presence of anti-FGL2 MAbs, and IL-17A expression was decreased in the presence of high
concentration of rFGL2 (5 μg/mL) and there was no influence on IL-17 expression upon expo-
sure to anti-FGL2-MAb (Fig 6A). The expression of CD62L, a cell adhesion molecule that is
abundant on naïve lymphocytes, but not expressed on effector memory T-lymphocytes [29],
was found to be increased on CD4+ T cells in the presence of rFGL2 (1 μg/mL), but decreased
in the presence of anti-FGL2 antibodies (Fig 6A). However, this was not the case upon analysis
of total spleen cell populations (S5 Fig), which indicated that FGL2 might play an important
role in down-regulating lymphocyte co-stimulation and effector T cell production.
For DCs, the expression of CD86 on CD11c+ DCs was decreased in the presence of rFGL2,
but increased in the presence of anti-FGL2 MAbs. However, expression of CD86 on CD11b+
DCs showed the opposite (Fig 6B).
Discussion
During infection with E.multilocularismetacestodes, immune tolerance and/or down-regula-
tion of immunity is a marked characteristic that becomes more pronounced at the later stage of
chronic disease in both humans [30] and in experimentally infected mice [5]. In the present
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study, we identified FGL2 as an important mediator of susceptibility to E.multilocularis infec-
tion in mice, and demonstrated for the first time that FGL2 a) partially contributes to Treg
functions; b) has the capacity to down-regulate the maturation of DCs; c) suppresses Th1- and
Th17-type immune responses; d) promotes Th2-biased and Treg immune responses; and final-
ly that e) IL-17A contributes to FGL2-secretion.
Fig 4. DCmaturation in both AE-WT and AE-fgl2-/-mice at 1 month and 4 months post-infection. (A) Representive images of CD80 mean fluorescence
intensity (MFI) in CD11b+ cells from AE-WT and AE-fgl2-/-mice, and non-infected mice as controls (4 months p.i.). (B) CD80 frequency within CD11b+ DCs in
PECs and spleen cells of AE-WT and AE-fgl2-/-mice. (C) CD80 frequency within CD11b+ DCs in spleen cells from AE-WT and AE-fgl2-/-mice, co-cultured
with ConA (2 μg/mL), normalized with their corresponding non-infected controls (we considered non-infected control as baseline, e.g. 1.0). (D) Representive
images of CD86 MFI in CD11b+ cells from AE-WT and AE-fgl2-/-mice, and non-infected mice as controls (4 months p.i.). (E) CD86 frequency within CD11b+
DCs in PECs and spleen cells of AE-WT and AE-fgl2-/-mice. (F) CD86 frequency within CD11b+ DCs in spleen cells from AE-WT and AE-fgl2-/-mice, co-
cultured with ConA (2 μg/mL), normalized with their corresponding non-infected controls (we considered non-infected control as baseline, e.g. 1.0). (G)
Representive images of CD80 MFI in CD11c+ cells from AE-WT and AE-fgl2-/-mice, and non-infected mice as controls (4 months p.i.). (H) CD80 frequency
within CD11c+ DCs in PECs and spleen cells of AE-WT and AE-fgl2-/-mice. (I) CD80 frequency within CD11c+ DCs in spleen cells from AE-WT and AE-
fgl2-/-mice, co-cultured with ConA (2 μg/mL), normalized with their corresponding non-infected controls (non-infected control as baseline, e.g. 1.0). The
corresponding isotype control antibodies were identically labeled for use as staining controls. Data represent mean±SD of three independent experiments of
a total of 15–18 mice in each group (5–6 mice per group in each independent experiment). Comparison between groups was performed using a one-way
ANOVA with Bonferroni’s multiple comparison post-test for statistical analysis. *P<0.01 for ex vivo assay, and *P<0.006 for in vitro assay. ‘WT’, wild type
mice; ‘fgl2-/-’, fgl2 knock-out mice; ‘AE-WT’, E.multilocularis-infected wild type mice; ‘AE-fgl2-/-’, E.multilocularis-infected fgl2 knock-out mice. ‘PEC’,
peritoneal exudate cells; ‘Spleen’, spleen cells.
doi:10.1371/journal.pntd.0003755.g004
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Earlier microarray-based data obtained from E.multilocularis-infected liver tissue have
shown that the peri-parasitic area is characterized by an increased FGL2 expression [7]. Since
Fig 5. T cell reactivity and DCmaturation in response to vesicle fluid (VF) in E.multilocularis infectedmice at 1 month and 4 months p.i. (A) Relative
expression level of T cell reactivity markers in spleen cells from AE-WT and AE-fgl2-/-mice, co-cultured with VF (10 μg/mL), in the presence of a protein
transport inhibitor cocktail (Ebioscience, San Diego, CA, USA), normalized using cells from non-infected controls as baseline (e.g. 1.0). (B) Relative
expression level of DCmaturation markers in spleen cells from infected AE-WT and AE-fgl2-/-mice, co-cultured with VF (10 μg/mL), normalized using cells
from non-infected controls. Data represent mean±SD of three independent experiments of a total of 15–18 mice in each group (5–6 mice per group in each
independent experiment). Comparison between groups was performed using a one-way ANOVA with Bonferroni’s multiple comparison post-test for
statistical analysis. *P<0.006. ‘WT’, wild type mice; ‘fgl2-/-’, fgl2 knock-out mice; ‘AE-WT’, E.multilocularis-infected wild type mice; ‘AE-fgl2-/-’, E.
multilocularis-infected fgl2 knock-out mice.
doi:10.1371/journal.pntd.0003755.g005
Fig 6. Recombinant FGL2 induces down regulation of T cell reactivity and DCmaturation in vitro. Different concentrations of recombinant FGL2 (0, 1,
5 μg/mL), ConA or vesicle fluid (VF), and anti-FGL2-MAb (1 μg/mL) were added to primary spleen cells isolated from non-infectedWTmice and cultured in
the presence of protein transport inhibitor cocktail. Relative expression level of T cell reactivity (A) and DCmaturation markers (B) were determined by flow
cytometry. Data represent mean±SD of three independent experiments of a total of 15–18 mice in each group (5–6 mice per group in each independent
experiment). Expression of each maker was normalized with cells without rFGL2 and anti-FGL2-MAb (negative control) as base line (e.g. as 1.0).
Comparison between groups was performed using a one-way ANOVA with Bonferroni’s multiple comparison post-test for statistical analysis. *P<0.006.
doi:10.1371/journal.pntd.0003755.g006
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immunomodulation is a hallmark of AE, and Treg cells are one of the key immune subsets to
mediate this effect, our objective was to study the role of Treg-expressed FGL2 in the outcome
of E.multilocularis infection. We originally hypothesized that upregulated FGL2-expression at
the host-parasite interface promotes parasite proliferation. Comparative analysis of E.multilo-
cularis growth in fgl2-/- mice versus WT mice at the late stage of infection showed clearly that
AE-WT mice exhibited a significantly higher parasite load as compared to AE-fgl2-/- mice. In
parallel, the parasite proliferation potential, assessed by determination of the E.multilocularis
em14-3-3 gene-expression-level, was significantly higher in AE-WT mice, and respectively
lower in AE-fgl2-/- animals. In previous experiments we had already documented that em14-3-
3-expression significantly increased upon reduced protective immunity such as encountered in
athymic nude mice, or decreased when the parasite growth was hindered as e.g. by albendazole
therapy [28,31]. AE-WT-mice also exhibited higher FGL2-levels in the serum as compared to
non-infected mice, elevated fgl2 mRNA expression levels in respective PEC and spleen cells,
and a concomitantly increased number of Tregs, which represent one of the major Treg pro-
ducers [9]. Taken together, these results support the hypothesis that Treg-expressed FGL2
contributes to the pathogenesis of E.multilocularis infection. In other infection models, such as
viral MHV-3 infection [10], similar results have been demonstrated, while no such effects
were found during protozoan (Toxoplasma gondii), bacterial (Yersinia enterocolitica, Listeria
monocytogenes, andMycobacterium tuberculosis), and other types of viral infections such as
murine gamma-herpesvirus-68 and Sendai infections [32]. The successful survival of patho-
gens depends mainly on evading the host immune response by, for example, varying their sur-
face antigens, eliminating their protein coat, and/or modulating the host immune response.
Immunosuppression is sometimes directly caused by pathogen-derived metabolic products,
and sometimes involves antigenic mimicry. One of the most sophisticated mechanisms of im-
mune evasion is the selective activation of a directly targeted subset of T helper cells. Different
pathogens may target different regulative pathways of the host immune response, such as Th2,
Tregs or Th17. It is known that the regulation of such pathways is not dependent on single
genes or molecules. Rather, a complex immuno-network is usually involved, which requires a
sophisticated modulatory process via specific modulatory molecules from E.multilocularis to
become effective, some may even act in combination or exert together a synergistic effect. Al-
ready know E.multilocularis bioactive molecules include e.g. Alkaline Phosphatase [33],
Em492 [34], EmTIP [7], among others; if these are involved in e.g. FGL2-induction needs to be
further explored.
How FGL2 influences and/or modulates the outcome of experimental AE is still largely un-
clear, although some of our study data provide first indications. In experimental AE [5,35,36],
the control of metacestode proliferation appears to be predominantly T cell-dependent, as as-
sessed upon use of different immune-compromised mouse models [27,31,37], and confirmed
by observations in human AE-patients with immune suppression-associated conditions [38–
41]. It is therefore conceivable that the proliferating metacestode itself specifically activates and
concurrently modulates the immune response to its own advantage. The metacestode appears
to secrete immuno-active metabolites to suppress the protective Th1-type response, and to pro-
mote a secondarily reinforced Th2-type response through functional induction and mainte-
nance of Treg cells [2, 25]. Tregs, which over-express a subset of regulatory cytokine genes
including those coding for IL-10 and TGF-β, play an important role in promoting immune tol-
erance in a number of parasitic disease models [42]. In AE, the expression of both cytokines ap-
pears up-regulated in mice as shown by different studies [39], and other studies strongly
suggested that they are also up-regulated in human AE-patients [43].
Various molecular and cellular mechanisms have been proposed to explain how Tregs sup-
press immune responses. These include cell-to-cell contact-dependent suppression,
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cytotoxicity, and immunoregulatory cytokine secretion such as IL-10 and TGF-β [44]. Howev-
er, the importance of these cytokines remains controversial, as several reports have demon-
strated that antibodies against IL-10 and TGF-β failed to block Treg suppressive function, and
Tregs from TGF-β–deficient mice retained normal suppressive activity in vitro [44]. In addi-
tion, the ambiguous role of TGF-β, which is both, a strong inducer of immune tolerance and
an activator of the pro-inflammatory IL-17 cytokine system, remains puzzling [45,46].
Undoubtedly, FGL2 represents an alternative candidate that could, at least partially, support
regulatory, and thus immunosuppressive, functions of Tregs. In Tregs of WT BALB/c mice,
FGL2 encoding mRNA is constitutively expressed at a high level, and expression even in-
creased after MHV-3 infection, and adoptive transfer of WT Tregs into MHV-3 resistant fgl2-/-
mice suggested that FGL2 might be an important Treg effector molecule [10]. Previous studies
on FGL2 had shown that rFGL2 suppressed T cell proliferation induced by anti-CD3/28 MAbs
and ConA [47,48]. In this study, we now demonstrated that rFGL2 suppressed CD4+ effector T
cell proliferation in response to E.multilocularis antigenic metabolites present in the metaces-
tode VF. We also showed that FGL2 inhibited the maturation of DCs, suppressed Th1 and
Th17 immune responses, and FGL2 polarized an allogeneic immune response towards a
Th2-oriented cytokine profile, both in vivo and in vitro. Conversely, in fgl2-/-mice, Th1 cyto-
kine levels and activity of DCs and T cells were all increased when compared to WT-animals,
and FGL2-serum-levels correlated with IL-4 expression in WT-mice before and after E.multi-
locularis infection. The development of a Th2-oriented immune response in WT-mice during
the course of E.multilocularis infection corroborated the generally known effect of FGL2 to
promote a Th2 cytokine production, with a concomitant inhibition of Th1- and Th17-oriented
immunity [47]. Furthermore, increased serum levels of IL-17A correlated with high FGL2
serum levels, suggesting for the first time that IL-17A could contribute to FGL2-secretion. This
was confirmed in vitro by the finding that recombinant IL-17A promoted the production of
FGL2 in spleen cells.
We also investigated whether FGL2 would affect the functional activities of Treg cells, by di-
rectly assessing the effects of rFGL2 and of an anti-FGL2-MAb on Treg activities in vitro. The
presence of recombinant FGL2 promoted Treg function, while addition of anti-FGL2-MAb
completely abrogated Treg activity. Further evidence for the role of FGL2 as a molecule that
promotes Treg function, and thus immunosuppression, was given by the observation that
fgl2-/- mice exhibited both decreased Treg numbers and impaired Treg function. The mecha-
nism by which FGL2 mediates its immunosuppressive activity is currently under investigation.
Previous studies have indicated that FGL2 binds to the inhibitory FcγRIIB receptor (CD32) ex-
pressed primarily on APCs. Both CD80 and CD86 ligands are found on APCs and are known
to provide efficient costimulation, however, in our experiments, distinct functions may be at-
tributed to CD80 and CD86. The differential functions of these molecules have already been
the subject of considerable studies, with most data suggesting that the two ligands share sub-
stantially overlapping functions. There is, however, also an increasing evidence that supports
the view that CD80 may be a more effective ligand for CTLA-4 than CD86 [49]. This
FGL2-FcγRIIB interaction through CD80 was shown to induce apoptosis in B cells, and to in-
hibit DC-maturation [11]. In E.multilocularis infection, several immune subsets may express
the FcγRIIB receptor, such as macrophages (including the ‘epithelioid cells’ that line the
‘immuno-modulating’ laminated layer), and also the numerous CD8+ T cells present in the
periparasitic infiltrate [50]; CD8+ T cells have actually been shown to express the FcγRIIB re-
ceptor in a murine model of Trypanosoma cruzi [51]. Taken our recent data on the course of
cytokine expression by the periparasitic immune infiltrate in E.multilocularis infection [4]
combined with the results from this study we propose that in E.multilocularis infected mice
the following events occur: (a) TNF-α, IFN-γ and IL-17A are released by the host at early stage
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of infection; (b) these cytokines, and especially IFN-γ as demonstrated previously [32] but also
IL-17A as shown in the present study, contribute to FGL2-secretion by Tregs and other cells;
and (c) secreted FGL2 can bind to FcγRIIB receptor, leads to a late-stage immune suppression
by down-regulating the maturation of DCs, decreases co-stimulation of effector T cells, sup-
presses Th1 and Th17 immune responses, and accelerates Th2 immune responses. Some para-
site's specific molecules may be involved in the modulation of FGL2, as discussed earlier.
Overall, this will lead to a periparasitic immune suppressed (anergic) status that favors the con-
tinuous “tumor-like” progression of the parasite (Fig 7). Direct inhibition of macrophage and/
or mast cell functions could also be induced by this interaction [24].
These findings on the role of FGL2 in E.multilocularis infection now open the door for
more applied approaches. For instance, the experimental treatment of E.multilocularis infected
mice with anti-FGL2-MAb could provide a means of converting the immunological anergy
during chronic disease into a more pro-active, Th1-oriented immunity, with potentially fatal
consequences for the metacestode. This is already under investigation. Furthermore, our find-
ings may provide a rationale for studying FGL2 as a target for an immunomodulatory
Fig 7. A schematic presentation of the hypothetical role of FGL2 in immune regulation during AE: E.multilocularismetabolites induce the release
of TNF-α, IFN-γ and IL-17; IFN-γ as demonstrated previously, but also IL-17A as presently demonstrated, contributes to FGL2 secretion by Tregs
and other cells; once FGL2 is released, it binds to FcγRIIB receptors, down-regulates the maturation of DCs, decreases co-stimulation of effector
T cells, suppresses Th1 and Th17 immune response, accelerates Th2 immune responses, and overall this leads to an immune suppressed status
that favors the continuous “tumor-like” progression of the parasitic metacestode.
doi:10.1371/journal.pntd.0003755.g007
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treatment option in patients with progressive AE. In addition, FGL2 may be proposed also as a
serum marker indicative for progression of E.multilocularis infection, may be useful to assess
the clinical status of AE-patients and the course and outcome and/or parasite activity in
human AE.
Supporting Information
S1 Fig. Gating strategy for the assessment of different cytokines and Foxp3. (A) Gating
strategy for the assessment of different cytokines: gate (G1) was positioned around lympho-
cytes, and cells within this gate were used for identifying CD4+ T cells. Cytokine frequency was
based on the fluorescence signal of different cytokine stainings; (B) Gating strategy for the as-
sessment of different cytokines: gate (G1) was positioned around lymphocytes, and cells within
this gate were used for identifying CD4+ T cells. Based on the fluorescence signal of the CD25
staining, CD25+ cells with bright fluorescence signal were distinguished as CD4+CD25+ cells
(G2). Within gate G2, Foxp3 histogram plots were used to determine the number of
Foxp3+ cells.
(TIF)
S2 Fig. Treg suppression assay. By using MACS and a followed FACS, CD4+CD25- Teff cells
(responders) were isolated from spleen cells of non-infected WTmice, CD4+CD25+ Tregs
(suppressor cells) were isolated from spleen cells of Control-WT mice (A), AE-WT mice (B),
Control- fgl2-/- mice (C), AE- fgl2-/- mice (D). CD4+CD25+ Tregs (suppressor cells) and
CD4+CD25- Teff cells (responder cells) were co-cultured at different suppressor: responder ra-
tios in the presence of syngeneic APCs and anti-CD3 antibody (0.5 μg/mL). Cell proliferation
was measured using BrdU ELISA. ‘WT’, wild type mice; ‘fgl2-/-’, fgl2 knock-out mice; ‘AE-WT’,
E.multilocularis-infected wild type mice; ‘AE-fgl2-/-’, E.multilocularis-infected fgl2 knock-
out mice.
(TIF)
S3 Fig. CD4+ T cell proliferation in WT and fgl2-/- mice at 4 months post E.multilocularis
infection. CD4+ T cells (Teffs) in the presence of APCs (A) or spleen cells (B) from AE-WT
and AE-fgl2-/- mice were cultured with ConA (2 μg/mL) for 48h. The presented data were nor-
malized with their own non-infected controls for statistical analyses (we considered non-in-
fected control as baseline, e.g. as 1.0). (C) Different concentrations of recombinant FGL2 (0, 1,
5 μg/mL), ConA or vesicle fluid (VF), and anti-FGL2-MAb (1 μg/mL) were added to primary
spleen cells isolated from AE-WTmice, compared to cultures from non-infected animals.
CD4+ T cell proliferation was determined by BrdU ELISA. Comparison between groups was
performed using a one-way ANOVA. P<0.05.
(TIF)
S4 Fig. FGL2 levels in supernatants from Tregs and Teffs cultures in the presence of APCs.
Experiments include WT and fgl2-/- mice at 4 months post E.multilocularis infection. Tregs
and CD4+ T cells (Teffs) in the presence of APCs from AE-WT and Control-WT mice were
cultured with VF (10 μg/mL) for 96h. FGL2-levels (culture supernatants) were determined by
ELISA. Data represent mean±SD of three independent experiments of a total of 15–18 mice for
each group (5–6 mice per group in each independent experiment). Comparison between
groups was performed using a one-way ANOVA. P<0.05.
(TIF)
S5 Fig. CD62L-expression in response to rFGL2 and anti-FGL2. Different concentrations of
recombinant FGL2 (0, 1, 2 μg/mL) and anti-FGL2-MAb (1 μg/mL), and PMA as a positive
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control, were added to primary spleen cells isolated from non-infected WT mice. CD62L-per-
centage in total spleen cells was determined by flow cytometry. Data represent mean±SD of
three independent experiments of a total of 15–18 mice for each group (5–6 mice per group in
each independent experiment). Comparison between groups was performed using a one-way
ANOVA P<0.05.
(TIF)
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